Chronic stress, immune imbalance, and thyroid dysfunction are deeply interconnected. This forms a stress–immune–thyroid triad where each system influences the others, affecting energy, mood, and resilience. Research shows that targeted support—including adaptogens, micronutrients can help restore communication across this network. Rather than offering quick fixes, this systems-based approach addresses underlying feedback loops, combining clinical insight, patient engagement, and supportive lifestyle practices to rebuild physiological balance and improve well-being over time.
Featured
Allergy Research Group Acquires Metabolic Maintenance
We're excited to announce the acquisition of Metabolic Maintenance, a respected provider of premium supplements known for its commitment to science-based formulations. This strategic acquisition further solidifies ARG’s position in the market and significantly enhances its portfolio, particularly in the burgeoning stress and mood management categories.
Read now
Calming the Stress–Immune–Thyroid Triad: Adaptogens + Nutrients That Support Balance
Read now
Beyond the Uterus: Why Progesterone Still Matters After Hysterectomy
The idea that women without a uterus don’t need progesterone is misleading. While progesterone is no longer required to protect the endometrium after hysterectomy, it still plays important systemic roles throughout the body. Progesterone receptors exist in the brain, bones, breasts, blood vessels, and immune cells, meaning it can influence mood, anxiety, sleep quality, cognition, bone formation, breast comfort, inflammation, and metabolic and cardiovascular function. Data shows the therapeutic use of bioidentical progesterone in the right context, though it is not a cure-all and must be paired with healthy lifestyle choices.
Read now
Estrogen: No Black Box Warning—Now What?
For more than two decades, fear stemming from early, oversimplified interpretations of the Women’s Health Initiative led many women and clinicians to avoid hormone replacement therapy, culminating in a black box warning on estrogen. In 2025, the FDA removed that warning for estrogen-only therapies, reflecting clearer evidence that risks depend heavily on age, timing, hormone type, and route of administration—not the universal danger once assumed. Updated research shows that starting hormone therapy within ten years of menopause, using bioidentical formulations, and choosing non-oral routes can significantly reduce risks, while estrogen-only therapy has not been shown to raise breast cancer risk. The label change does not mean hormone therapy is risk-free, but it does open the door to individualized, evidence-based decision-making. With better data and more nuance, women and clinicians can move forward with informed conversations rather than fear-driven avoidance.
Read now
Alpha Brain Waves for Sleep
Discover how alpha brain waves boost relaxation, sleep quality, creativity, and resilience—and learn simple ways to enhance them daily.
Read now
Social Wellness vs. Self-Care: Why Social Connection Matters for Mental Health
Learn about what exactly social wellness is, and why its so crucial to maintaining your mental health.
Read now
Methylated Vitamins: Why We Need the “Methyl” in MethylPro
Let's explore the science of methylation and how methylated vitamins play a pivotal role in mental wellbeing.
Read now
